CD4 and neoplasm: DC have MHC class I and II molecules on their surface, which when combined with antigenic peptides trigger CD4+ helper T cells (Th) and CD8+ cytotoxic T lymphocytes (CTL) to elicit specific anti-tumour cellular and humoral immunity, inhibiting tumour cell growth (117).